Trials / Completed
CompletedNCT04984681
Feasibility of the Mindfulness-Based Stress Reduction Intervention for Black Women Living With HIV Supplement
Feasibility of the Mindfulness-Based Stress Reduction Intervention for Black Women Living With HIV Administrative Supplement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In our Supplement Aim we will conduct a two-arm randomized pilot test of the adapted intervention compared to a usual care control group among 30 African American/Black women with HIV (15/arm) to assess the feasibility and acceptability of the mindfulness-based stress reduction among women with HIV with mild cognitive impairment. Feasibility will be assessed by our ability to (1) recruit, randomize, and retain participants and (2) deliver the intervention per the manual, as well as (3) participants adherence to home practices and assignments. Acceptability will be assessed via qualitative data (focus group input regarding participants' satisfaction with the intervention and intent to continue using the practices), as well quantitative data (satisfaction survey).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mindfulness | The traditional mindfulness intervention consists of the following: (1) orientation; (2) a series of eight weekly session of 2.5 to 3 hours; (3) a silent retreat during the between weeks 4 and 6; (4) daily home assignments including formal and informal mindfulness practices; and (5) didactic presentations on stress and the consequences of stress. |
| OTHER | Usual Care | The control condition will continue receiving usual care or standard of care. |
Timeline
- Start date
- 2022-03-02
- Primary completion
- 2022-11-10
- Completion
- 2022-12-14
- First posted
- 2021-07-30
- Last updated
- 2024-10-01
- Results posted
- 2024-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04984681. Inclusion in this directory is not an endorsement.